Syngene Scientific Solutions Profile
Key Indicators
- Authorised Capital ₹ 500.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 84.00 Cr
as on 05-12-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Syngene Scientific Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 500.00 Cr and a paid-up capital of Rs 84.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Syngene Scientific Solutions Limited India are Ganesan Krishnan as CFO and Daksh Arora as Company Secretary. Sibaji Biswas, Kenneth Barr, and Jayashree Aiyar serve as directors at the Company.
- CIN/LLPIN
U73200KA2022PLC164804
- Company No.
164804
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2022
- Date of AGM
19 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Syngene Scientific Solutions?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesan Krishnan | CFO | 29-Sep-2023 | Current |
| Daksh Arora | Company Secretary | 29-Sep-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sibaji Biswas  | Director | 10-Aug-2022 | Current |
| Kenneth Barr | Director | 24-Mar-2023 | Current |
| Jayashree Aiyar | Director | 31-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Syngene Scientific Solutions.
Syngene Scientific Solutions Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Syngene Scientific Solutions?
In 2023, Syngene Scientific Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syngene Scientific Solutions?
Unlock and access historical data on people associated with Syngene Scientific Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syngene Scientific Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngene Scientific Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
